VYOME HOLDINGS, INC. Repayments of Convertible Debt
VYOME HOLDINGS, INC. (HIND) reported Repayments of Convertible Debt of $811.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2025-08-14
- VYOME HOLDINGS, INC. repayments of convertible debt for the quarter ending 2025-06-30 was $0.00.
- VYOME HOLDINGS, INC. repayments of convertible debt for the quarter ending 2025-03-31 was $811.00K.
| Period end | Repayments of Convertible Debt 1 month | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month |
|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $811.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $811.00K 10-Q · filed 2025-05-20 | ||
| 2025-02-28 | $800.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |